Pliant Therapeutics Ownership | Who Owns Pliant Therapeutics?

Pliant Therapeutics Ownership Summary

Pliant Therapeutics is owned by 94.56% institutional investors, 3.04% insiders, and 2.39% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 9.83% of PLRX shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 3.84% of its assets in Pliant Therapeutics shares.

PLRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pliant Therapeutics	94.56%	3.04%	2.39%
Sector	Healthcare Stocks	278.45%	10.60%	-189.04%
Industry	Biotech Stocks	63.84%	10.66%	25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Deep track capital, lp	5.97M	9.83%	$78.65M
Blackrock funding, inc. /de	5.18M	8.53%	$68.22M
Blackrock	4.97M	8.26%	$53.45M
Price t rowe associates inc /md/	4.63M	7.63%	$61.04M
Fmr	3.88M	6.38%	$51.05M
Vanguard group	3.23M	5.32%	$42.52M
Redmile group	2.90M	4.77%	$38.13M
Blue owl capital lp	2.77M	4.56%	$36.47M
Deutsche bank ag\	2.55M	4.20%	$33.61M
Trv gp iv	2.13M	3.51%	$28.09M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Trv gp iv	2.13M	35.03%	$28.09M
Mass general brigham	288.69K	15.11%	$3.10M
Blue owl capital lp	2.77M	8.40%	$36.47M
Great point partners	1.05M	6.55%	$13.89M
Deep track capital, lp	5.97M	2.93%	$78.65M
Redmile group	2.90M	2.66%	$38.13M
Fernwood investment management	425.42K	1.95%	$5.60M
Highmark wealth management	75.00K	0.57%	$987.75K
Bond & devick financial network	100.16K	0.48%	$1.12M
Rock springs capital management lp	404.80K	0.20%	$5.33M

Top Buyers

Holder	Shares	% Assets	Change
Deutsche bank ag\	2.55M	0.01%	1.02M
Ubs group	628.28K	0.00%	397.97K
Blackrock	4.97M	0.00%	316.25K
Morgan stanley	673.85K	0.00%	289.75K
Jpmorgan chase	197.25K	0.00%	148.04K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-3.20M
Laurion capital management lp	-	-	-2.50M
Polar capital	-	-	-2.02M
First light asset management	-	-	-1.68M
Silverarc capital management	-	-	-1.32M

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	53.88K	0.00%	53.88K	$709.60K
D. e. shaw	10.68K	0.00%	10.68K	$114.80K
Bnp paribas arbitrage, snc	7.51K	0.00%	7.51K	$98.93K
Mai capital management	400.00	-	400.00	$5.27K
Amundi	52.00	-	52.00	$656.00

Sold Out

Holder	Change
Mine & arao wealth creation & management, llc.	-2.00
Allworth financial lp	-2.00
National bank of canada /fi/	-8.00
Nelson, van denburg & campbell wealth management group	-11.00
Financial gravity asset management	-19.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	142	-13.41%	57,894,025	-10.59%	94	0.83%	75	-5.06%	39	-4.88%
Dec 31, 2024	70	-55.70%	15,788,963	-75.13%	25	0.24%	37	-54.88%	12	-62.50%
Sep 30, 2024	158	6.76%	63,495,937	-0.63%	104	0.93%	83	6.41%	31	-6.06%
Jun 30, 2024	148	4.96%	63,899,831	-1.97%	106	0.91%	78	21.88%	33	-10.81%
Mar 31, 2024	141	-	65,187,222	3.95%	108	0.95%	64	-9.86%	37	15.63%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	2.34M	3.84%	-75.06K
T. Rowe Price New Horizons	2.34M	3.82%	-676.00
DWS ESG Akkumula LC	2.30M	3.76%	-4.00
Vanguard US Total Market Shares ETF	2.03M	3.32%	-
Polar Capital Biotech S Inc	1.85M	3.02%	-
Fidelity Growth Compy Commingled Pl S	1.82M	2.96%	-
Vanguard Total Stock Mkt Idx Inv	1.79M	2.92%	-
Fidelity Growth Compy Commingled Pl O	1.77M	2.91%	-
iShares Russell 2000 ETF	1.59M	2.59%	780.00
Fidelity Growth Company Fund	1.29M	2.11%	-2.64K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 17, 2025	Coulie Bernard	President and CEO	Sell	$587.15K
Jan 17, 2025	Cummings Keith Lamont	Chief Financial Officer	Sell	$225.68K
Jan 17, 2025	Hull Hans	Chief Business Officer	Sell	$178.50K
Jan 17, 2025	Lefebvre Eric	Chief Medical Officer	Sell	$206.97K
Jan 17, 2025	Cheung Lily	Chief Human Resource Officer	Sell	$41.89K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	7
2024 Q3	-	5
2024 Q2	-	-
2024 Q1	-	5
2023 Q3	-	9

PLRX Ownership FAQ

Who Owns Pliant Therapeutics?

Pliant Therapeutics shareholders are primarily institutional investors at 94.56%, followed by 3.04% insiders and 2.40% retail investors. The average institutional ownership in Pliant Therapeutics's industry, Biotech Stocks , is 63.84%, which Pliant Therapeutics exceeds.

Who owns the most shares of Pliant Therapeutics?

Pliant Therapeutics’s largest shareholders are Deep track capital, lp (5.97M shares, 9.83%), Blackrock funding, inc. /de (5.18M shares, 8.53%), and Blackrock (4.97M shares, 8.26%). Together, they hold 26.62% of Pliant Therapeutics’s total shares outstanding.

Does Blackrock own Pliant Therapeutics?

Yes, BlackRock owns 8.26% of Pliant Therapeutics, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 53.45M$. In the last quarter, BlackRock increased its holdings by 316.25K shares, a 6.79% change.

Who is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested, with 35.03% of its assets in 2.13M Pliant Therapeutics shares, valued at 28.09M$.

Who is the top mutual fund holder of Pliant Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Pliant Therapeutics shares, with 3.84% of its total shares outstanding invested in 2.34M Pliant Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools